Procter & Gamble Reports Fiscal Q1 This Week: Gross Margin, Not Sales, Decides the Quarter
Procter & Gamble reports fiscal first-quarter results on Thursday, October 22, before the open. Consensus calls for EPS of $1.88 on revenue of $22.80 billion, which would mean lower earnings than a year ago despite higher sales. Whether gross margin stops sliding after two quarters below 50% will decide how the quarter reads.
Maz Vantage Research ·
Procter & Gamble reports results for its fiscal first quarter of 2027 (the three months to September 30, 2026) on Thursday, October 22, before the market opens. On the surface, the consensus looks unremarkable: modest sales growth and a slightly lower profit. Underneath, the gap between those two numbers is the whole story. Analysts expect revenue to rise while earnings per share fall, which means the quarter will be judged on margins rather than on volume.
What the street expects
The consensus calls for earnings per share of $1.88 on revenue of $22.80 billion. In the same quarter a year ago, P&G earned $1.99 per share on revenue of $22.39 billion.
| Fiscal Q1 (Sep quarter) | Consensus FY2027 | Actual FY2026 | Change |
|---|---|---|---|
| EPS | $1.88 | $1.99 | -5.5% |
| Revenue | $22.80B | $22.39B | +1.8% |
Change columns are simple arithmetic on the consensus and last year's actuals.
A 1.8% increase in revenue paired with a 5.5% decline in EPS is an unusual setup for a company whose appeal rests on steady compounding. It implies the street already expects a meaningful squeeze somewhere between the top line and the bottom line.
The track record
P&G has been a reliable beater on earnings and an inconsistent one on sales. Over the last four reported quarters:
- July 2026 (fiscal Q4 2026): EPS $1.43 vs $1.41 expected (beat); revenue $21.20B vs $21.38B expected (miss).
- April 2026 (fiscal Q3): EPS $1.59 vs $1.56 (beat); revenue $21.24B vs $20.53B (beat).
- January 2026 (fiscal Q2): EPS $1.88 vs $1.86 (beat); revenue $22.21B vs $22.30B (miss).
- October 2025 (fiscal Q1): EPS $1.99 vs $1.90 (beat); revenue $22.39B vs $22.18B (beat).
That is four EPS beats out of four and two revenue beats out of four. The EPS beats have been narrow, typically two or three cents, apart from the nine-cent margin a year ago. The most recent quarter is worth noting: EPS of $1.43 was below the $1.48 reported in the same quarter of the prior year, even though revenue grew about 1.5% to $21.20 billion. That is the same pattern the consensus now projects for the September quarter.
The line that decides the quarter
The line to watch is gross margin. Revenue growth in the low single digits is roughly what P&G has delivered for some time; what has changed is how much of each sales dollar it keeps.
From the filed quarterly accounts, gross margin has moved as follows (gross profit divided by revenue):
- September 2025 quarter: 51.4%
- December 2025 quarter: 51.2%
- March 2026 quarter: 49.5%
- June 2026 quarter: 48.5%
Operating margin fell further over the same period, from 26.2% in the September 2025 quarter to 18.6% in the June 2026 quarter. In the June quarter, selling, general and administrative expense rose to $6.34 billion, or 29.9% of revenue, compared with 28.3% a year earlier. Part of the operating-margin decline therefore came from higher spending, not only from the cost of goods.
The year-ago comparison is demanding: the September 2025 quarter carried the highest gross margin of the last five reported quarters. If the company reports a gross margin closer to 51% than to 48.5%, the EPS consensus of $1.88 looks conservative and the slide of the past two quarters starts to look like a seasonal or temporary dip. If the margin stays near the June level, the consensus decline in EPS is probably the right picture, and the question shifts to how long the pressure lasts.
Recent coverage points in the same direction. A Zacks note this week, "Procter & Gamble's Innovation Push: Catalyst for Long-Term Growth?", framed the company's innovation and productivity programmes as an effort to revive organic sales growth. Productivity savings are exactly what would show up in gross margin, so this quarter is a test of whether that effort is reaching the income statement.
Valuation and the Maz Rating
At $157.69, P&G has a market value of about $366 billion and trades at 23.4 times trailing earnings, with a trailing dividend yield of about 2.7%. The shares sit between a 52-week low of $137.62 and a high of $167.25, and above their 50-day average of $147.11. The analyst price-target consensus is $160.13 (median $163.50, range $149 to $172), about 1.5% above the current price by simple arithmetic.
P&G carries a Maz Rating of 3.89 out of 5 (Buy). The factor scores explain the mix: Profitability scores 4.98 and Momentum 4.03, while Financial Health is 3.79. The weak spots are Growth at 2.56 and Valuation at 1.16. In other words, the rating rewards the quality of the business and the recent price trend, and already discounts both a full multiple and slow growth. A further leg down in margins would hit the strongest factor in that profile.
Bottom line
The consensus already assumes P&G will earn less this quarter than a year ago despite selling more. Whether the result reads as good or bad depends less on the revenue figure, which has stayed close to estimates in either direction, and more on whether gross margin stops falling after two consecutive quarters below 50%. Revenue and EPS will make the headlines; the margin line will tell investors whether the pressure is easing.
This is a preview based on published consensus and filed accounts, not investment advice.